About SARS-CoV-2 rS Protein recombinant spike protein Nanoparticle Vaccine
            
            Class: | Vaccine (recombinant protein subunit vaccine)  
Use: | Prevention of COVID-19 caused by SARS-CoV-2  
Adult dose: | 5 mcg administered as a 0.5 ml intramuscular injection, typically given in a two-dose series, with the second dose administered 21 days after the first  
Pediatric dose: | Safety and efficacy not established for individuals under 18 years; consult local guidelines for pediatric use  
Side effects: | Common side effects include pain at the injection site, fatigue, headache, 
         
        
            
                
                
                    
                        Drug Class
                    
                    Vaccine (recombinant protein subunit vaccine)
                 
                
                
                    
                        Uses & Indications
                    
                    Prevention of COVID-19 caused by SARS-CoV-2
                 
                
                
                    
                        Storage Requirements
                    
                    Store in a refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Serum Institute of India Ltd., INDIA
                    
                    
                    Package Size
                    0.5ml vial
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 0.10
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        5 mcg administered as a 0.5 ml intramuscular injection, typically given in a two-dose series, with the second dose administered 21 days after the first
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established for individuals under 18 years; consult local guidelines for pediatric use
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include pain at the injection site, fatigue, headache, muscle pain, joint pain, chills, fever, and nausea
                 
             
         
        
        
            
                Contraindications & Precautions
            
            History of severe allergic reaction (anaphylaxis) to any component of the vaccine; caution in individuals with a history of allergic reactions
         
        
        
            
                Important Warnings
            
            Monitor for allergic reactions post-vaccination; individuals with a history of myocarditis or pericarditis following mRNA COVID-19 vaccines should consult healthcare providers before vaccination; not recommended for individuals with acute illness or fever at the time of vaccination
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.